Last updated on February 2019

An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Patients With Previously Treated Cancer of the Colon or Rectum That Has Spread


Brief description of study

The purpose of this study is to investigate treatment with Nivolumab in combination with Trametinib with or without Ipilimumab in patients with previously treated cancer of the colon or rectum that has spread.

Clinical Study Identifier: NCT03377361

Contact Investigators or Research Sites near you

Start Over

Local Institution

Brussels, Belgium
6.69miles
  Connect »

Local Institution

Bruxelles, Belgium
7.84miles
  Connect »

Local Institution

Brussel, Belgium
8.97miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.